Results 181 to 190 of about 4,251,800 (292)

Transfer function analysis of dynamic cerebral autoregulation: A CARNet white paper 2022 update. [PDF]

J Cereb Blood Flow Metab, 2023
Panerai RB, Brassard P, Burma JS, Castro P, Claassen JA, van Lieshout JJ, Liu J, Lucas SJ, Minhas JS, Mitsis GD, Nogueira RC, Ogoh S, Payne SJ, Rickards CA, Robertson AD, Rodrigues GD, Smirl JD, Simpson DM, Cerebrovascular Research Network (CARNet).   +18 more
europepmc   +1 more source

E2A selectively regulates TGF‐β–induced apoptosis in KRAS‐mutant non‐small cell lung cancer

Molecular Oncology, EarlyView.
Ability to induce apoptosis by TGF‐β is frequently lost in advanced lung adenocarcinoma despite intact TGF‐β signaling. We identify E2A as a mutant KRAS–dependent mediator of resistance to TGF‐β–induced apoptosis. TGF‐β induces E2A via SMAD3 in mutant KRAS cells, and E2A silencing restores apoptosis and enhances radiation response in cell lines ...
Sergei Chuikov, Shiva Krishna Katkam, Zhefan Wang, Venkateshwar G. Keshamouni   +3 more
wiley   +1 more source

2D logistic map with unit transfer function and modulus operation based pseudorandom number generation for image encryption. [PDF]

Sci Rep
Ahmad R, Said G, Flah A, Kraiem H, El Bayeh CZ, Khattak YH, Baig F.   +6 more
europepmc   +1 more source

Enhancing Applicability of Reversible UV Thermochromic Offset Inks: Edge Quality Parameters and Thermochromic Printing System Modulation Transfer Function. [PDF]

Materials (Basel), 2023
Jakopčević Z, Itrić Ivanda K, Kulčar R, Pasanec Preprotić S, Vukoje M.   +4 more
europepmc   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

Experimental assessment of the optical transfer function for quantitative oblique back illumination microscopy (qOBM). [PDF]

Opt Express
Li Z, Casteleiro Costa P, Serafini C, Bharadwaj S, Guang Z, Robles FE.   +5 more
europepmc   +1 more source

Diagnostic and prognostic performance of Mxa and transfer function analysis-based dynamic cerebral autoregulation metrics. [PDF]

J Cereb Blood Flow Metab, 2022
Olsen MH, Riberholt C, Plovsing RR, Berg RM, Møller K.   +4 more
europepmc   +1 more source

Heterozygous loss‐of‐function alleles associate the conserved 3′‐5′ exoribonuclease EXOSC10 with hypersensitivity to the anticancer drug 5‐fluorouracil

Molecular Oncology, EarlyView.
EXOSC10, an essential nuclear RNA exosome‐associated 3′‐5′ exoribonuclease, is inhibited by the anticancer drug 5‐fluorouracil (5‐FU), and EXOSC10 depletion increases 5‐FU sensitivity. The colon‐cancer variant EXOSC10S402T, located in a proteolysis motif, is stable and nuclear but nonfunctional in vivo.
Radhika Sain, Yann Le Page, Frédéric Percevault, Emmanuelle Becker, Luc Negroni, Almudena Fernandez, Marta Cantero, Diego Muñoz‐Santos, Lluís Montoliu, Cyrille Garnier, Michael Primig   +10 more
wiley   +1 more source

Model-agnostic neural mean field with a data-driven transfer function. [PDF]

Neuromorphic Comput Eng
Spaeth A, Haussler D, Teodorescu M.
europepmc   +1 more source

Phospholipid transfer function of PTPIP51 at mitochondria-associated ER membranes. [PDF]

EMBO Rep, 2021
Yeo HK, Park TH, Kim HY, Jang H, Lee J, Hwang GS, Ryu SE, Park SH, Song HK, Ban HS, Yoon HJ, Lee BI.   +11 more
europepmc   +1 more source